Rational Vaccines

About Rational Vaccines

Rational Vaccines is an investigational-stage infectious disease company focused on combating diseases caused by herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2). Their mission is to reduce suffering, prevent the spread of the virus, and revolutionize the treatment, prevention, and diagnosis of herpes and related diseases worldwide, envisioning a future free of herpes.

Products & Services

Live Attenuated Viral Vaccines:Developing rationally engineered, live attenuated viral immunotherapeutic and prophylactic vaccine candidates to treat and prevent herpes infections.

COVID-19 Technology:Utilizing proprietary technology to combat COVID-19, with further details available on their website.

Specialties

Infectious Diseases Herpes Simplex Virus (HSV-1 and HSV-2) Live Attenuated Vaccines Immunotherapy Prophylactic Vaccines

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 2800000 MR: - FA: 2.8 million FAN: 2800000	D: 2023-10-13 FD: 2023-10-13	1 investors

Grant Latest

2023-10-13

$2.8M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Kerstin Westritschnig

Chief Medical Officer

A

Agustin Fernandez

Chief Executive Officer

O

Olivier Jarry

Chief Financial Officer

D

David Brindley

Chief Regulatory & IP Officer

E

Edward Gershburg

Chief Technology Officer

K

Konstantin Kousoulas

VP of Scientific Affairs

View 25 more team members with Pro

Unlock Full Team Directory

Recent News